Literature DB >> 9404986

Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage.

S L Engelhardt1, M J Schurr, R B Helgerson.   

Abstract

Toxic epidermal necrolysis (TEN) is an exfoliative disorder associated with epidermal slough and systemic toxicity. As of 1986, the literature has advocated early burn center transfer and has rejected the use of steroids. We questioned whether therapy for TEN has changed to reflect these concepts. All cases of TEN referred to our tertiary burn center since 1988 were reviewed. The history was evaluated for steroid usage and timing of burn center transfer. Drug exposures, septic complications, and deaths were noted. Statistics are expressed as mean +/- SD. Fourteen cases of TEN were identified. Transfer was delayed more than 2 days in 10 (72%) instances. Mean delay was 4.4 +/- 2.7 days. Half received steroids. There were three deaths (21%). Pneumonia developed in five patients (36%), urinary tract infections developed in three (21%) patients, seven (50%) patients required intubation, and three (21%) required hemodialysis. No differences in mortality rates or infectious complications were noted in patients who received steroids or who were transferred late. Septic complications occur frequently in TEN. Delay in transfer and initiation of steroids at referring institutions are common. Early burn center referral and avoidance of steroids needs to be reiterated at the level of the referring physician.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9404986

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  4 in total

1.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

2.  IVIG and under Burn Unit Care Yield Favorable Outcomes in Pediatric Patients with Toxic Epidermal Necrolysis: A Case Report and Literature Review.

Authors:  Tareq Z Alzughayyar; Wasim Noureddin Ibrahim Hamad; Eman A S Abuqweider; Bilal Nabeel Mohammad Alqam; Sadi A Abukhalaf; Rami A Misk; Fawzy M Abunejma; Jihad Samer Zalloum; Mohanad Saleh; Ali A Abumunshar; Yousef I M Zatari
Journal:  Case Rep Dermatol Med       Date:  2020-01-30

3.  Severe erythema multiforme-type drug eruption controlled by tumor necrosis factor-α antagonist: A case study.

Authors:  Xin Ling; Xin Shi; Lingling Chen
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

4.  Toxic epidermal necrolysis and concurrent granulomatosis with polyangiitis (Wegener's granulomatosis). Management of a rare case and review of the literature.

Authors:  Stratos S Sofos; J Ewing; L C Hughes; M I James
Journal:  Scars Burn Heal       Date:  2016-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.